ImmunityBio Statistics
NASDAQ: IBRXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
9.75+0.06 (+0.62%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ImmunityBio by the numbers
ImmunityBio has a market capitalization of $10.33 billion based on 1.06B shares outstanding. With trailing EPS of $-0.97, ImmunityBio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 20.1% above its 50-day average and 33.8% above its 200-day average.
Average daily trading volume is 10.27M shares, or about $100.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IBRX valuation vs. peer median
| Metric | IBRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $10.33B | $9.79B | +6% |
| Avg. volume | 10.27M | 1.71M | +499% |
Peer median across 8 companies: TWST, PCVX, KRYS, QGEN, TECH, KYMR, HALO, IMVT.
Valuation
- Market cap
- $10.33B
- Price / sales (latest FY)
- 91.21
- EPS (TTM)
- $-0.97
- Shares outstanding
- 1.06B
Price and trading
- Previous close
- 9.69
- Open
- 9.48
- Day range
- 9.33 – 9.93
- 52-week range
- 1.95 – 12.43
- 52-week change
- +290.00%
- Beta
- —
- Volume
- 11.75M
- Average volume
- 10.27M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 10.33B
- Forward Pe
- -69.64
- Eps
- -0.97
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 12.43
- Week52 Low
- 1.95
- Avg Volume
- 10.27M
- Shares Outstanding
- 1.06B
- Ma50
- 8.12
- Ma200
- 7.28
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -21.56%
- Pct From52w Low
- 400.00%